Topical 5-fluorouracil is ineffective in the treatment of extensive alopecia areata

Journal of the American Academy of Dermatology

Volumn 50, Issue 6, 2004, Pages 941-943

  Kaplan, Andrew L ^a,b   Olsen, Elise A ^a,b  

^a Duke University Medical Center ^*

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ALOPECIA AREATA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREAM; DRUG EFFICACY; FEMALE; HAIR GROWTH; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; SCALP HAIR; SKIN IRRITATION;

EID: 2542430308     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.01.046     Document Type: Article

References (16)

1. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549-66.
2. Chan PD, Berk MA, Kucuk O, Singh S. Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ ABV chemotherapy. Med Pediatr Oncol 1992;20:345-8.
3. Arrazola JM, Sendagorta E, Harto A, Ledo A. Treatment of a lopecia areata with topical nitrogen mustard. Int J Dermatol 1985;24:608-10.
4. Bernardo O, Tang L, Lui H, Shapiro J. Topical nitrogen mustard in the treatment of alopecia areata: a bilateral comparison study. J Am Acad Dermatol 2003;49:291-4.
5. Sams WM. Untoward response with topical fluorouracil. Arch Dermatol 1968;97:14-22.
6. Goette DK, Odom RB. Allergic contact dermatitis to topical fluorouracil. Arch Dermatol 1977;13:1058-61.
7. Epstein E. Hidden fluorouracil applications as a cause of dermatitis and erosions. JAMA 1983;249:1565-6.
8. Shelley WB, Shelley ED. Scrotal dermatitis caused by 5-flourouracil (Efudex). J Am Acad Dermatol 1988;19:929-31.
9. Cullen SI. Topical fluorouracil therapy for precancers and cancers of the skin. Am Geriatr Soc 1979;12:529-35.
10. Gereis M, Burford-Mason AP, Watkins SM. Suppression of in vitro peripheral blood lymphocyte mitogenesis by cytotoxic drugs commonly used in the treatment of breast cancer: a comparative study. Agents Actions 1987;22:324-9.
11. Boumah CE, Setterfield G, Kaplan JG. Purine and pyrimidine analogues irreversibly prevent passage of lymphocytes from the G1 to the S phase of the cell cycle. Can J Biochem Cell Biol 1984;62:280-7.
12. Nordman E, Saarimaa H, Toivanen A. The influence of 5-fluorouracil on cellular and humoral immunity in cancer patients. Cancer 1978;41:64-9.
13. Okamoto M, Ohe G, Oshikawa T, Nishikawa H, Furuichi S, Yoshida H, et al. Induction of cytokines and killer cell activities by cisplatin and 5-fluorouracil in head and neck cancer patients. Anticancer Drugs 2000;11:165-73.
14. Olsen EA, Hordinsky M, Price V, et al. Alopecia areata investigational guidelines: part 2. J Am Acad Dermatol In press.
15. Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J, et al. Alopecia areata investigational assessment guidelines. J Am Acad Dermatol 1999;40:242-6.
16. Wiseman MC, Shapiro J, MacDonald N, Lui H. Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 2001;37:1063-8.